Suchergebnisse - "Mitri, Jennifer"

PubPharm (7)

1

Activity of axial spondyloarthritis after one year of anti-tumor necrosis factor therapy among patients with inflammatory bowel diseases

enthalten in: Clinical rheumatology | 2023

von Dalal, R. | Ermann, J. | Carlin, A. | +2

2

Risk of Gastrointestinal Infections After Initiating Vedolizumab and Anti-TNFα Agents for Ulcerative Colitis

enthalten in: Journal of clinical gastroenterology | 2023

von Dalal, R. | Mitri, J. | Goodrick, H. | +1

3

Low-Dose Interleukin 2 for the Treatment of Moderate to Severe Ulcerative Colitis

enthalten in: Gastroenterology | 2023

von Allegretti, J. | Mitsialis, V. | Canavan, J. | +30

4

Activity of axial spondyloarthritis after one year of anti-tumor necrosis factor therapy among patients with inflammatory bowel diseases

enthalten in: Clinical rheumatology | 2023

von Dalal, R. | Ermann, J. | Carlin, A. | +2

5

Outcomes of Standard and Intensified Dosing of Ustekinumab for Chronic Pouch Disorders

enthalten in: Inflammatory bowel diseases | 2022

von Dalal, R. | Gupta, S. | Goodrick, H. | +2

6

P074 Comparative Risk of Clostridioides Difficile Infection in Vedolizumab vs anti-TNFa Agents in Biologic-Naïve Patients With Ulcerative Colitis

enthalten in: The American journal of gastroenterology | 2021

von Dalal, R. | Mitri, J. | Goodrick, H. | +1

7

Real-World Comparison of Tofacitinib vs Ustekinumab Among Bio-Exposed Patients With Ulcerative Colitis : A Propensity Score Analysis

enthalten in: Inflammatory bowel diseases | 2021

von Dalal, R. | Mitri, J. | Goodrick, H. | +1

1
[1]